West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. grew its holdings in West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) by 1.7% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 137,784 shares of the medical instruments supplier’s stock after buying an additional 2,314 shares during the quarter. Russell Investments Group Ltd.’s holdings in West Pharmaceutical Services were worth $33,937,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of West Pharmaceutical Services by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier’s stock valued at $3,579,876,000 after buying an additional 82,459 shares during the period. FMR LLC lifted its holdings in shares of West Pharmaceutical Services by 0.3% in the 2nd quarter. FMR LLC now owns 2,038,259 shares of the medical instruments supplier’s stock valued at $616,309,000 after buying an additional 5,718 shares during the period. WCM Investment Management LLC lifted its holdings in shares of West Pharmaceutical Services by 12.2% in the 3rd quarter. WCM Investment Management LLC now owns 1,236,059 shares of the medical instruments supplier’s stock valued at $310,585,000 after buying an additional 134,020 shares during the period. Artisan Partners Limited Partnership raised its holdings in West Pharmaceutical Services by 56.6% during the second quarter. Artisan Partners Limited Partnership now owns 853,248 shares of the medical instruments supplier’s stock worth $257,997,000 after purchasing an additional 308,549 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in West Pharmaceutical Services by 10.5% during the first quarter. Goldman Sachs Group Inc. now owns 558,745 shares of the medical instruments supplier’s stock worth $229,483,000 after purchasing an additional 53,044 shares during the last quarter. 91.51% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Eric Mark Green sold 44,000 shares of West Pharmaceutical Services stock in a transaction on Monday, December 5th. The stock was sold at an average price of $238.99, for a total value of $10,515,560.00. Following the completion of the sale, the chief executive officer now owns 114,922 shares of the company’s stock, valued at $27,465,208.78. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.60% of the company’s stock.

West Pharmaceutical Services Stock Performance

West Pharmaceutical Services stock opened at $258.33 on Wednesday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.89 and a current ratio of 3.80. The stock has a fifty day moving average of $238.50 and a two-hundred day moving average of $266.35. The company has a market capitalization of $19.12 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 2.44 and a beta of 1.12. West Pharmaceutical Services, Inc. has a fifty-two week low of $206.19 and a fifty-two week high of $424.00.

West Pharmaceutical Services (NYSE:WSTGet Rating) last announced its quarterly earnings data on Thursday, October 27th. The medical instruments supplier reported $2.03 EPS for the quarter, missing analysts’ consensus estimates of $2.12 by ($0.09). The business had revenue of $686.90 million during the quarter, compared to analysts’ expectations of $730.64 million. West Pharmaceutical Services had a net margin of 21.68% and a return on equity of 28.15%. On average, analysts anticipate that West Pharmaceutical Services, Inc. will post 8.18 EPS for the current fiscal year.

West Pharmaceutical Services Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 1st. Stockholders of record on Wednesday, January 25th will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Tuesday, January 24th. West Pharmaceutical Services’s dividend payout ratio is currently 9.17%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Bank of America cut West Pharmaceutical Services from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $385.00 to $250.00 in a report on Friday, October 28th. KeyCorp reduced their price objective on West Pharmaceutical Services from $350.00 to $315.00 and set an “overweight” rating for the company in a report on Friday, December 2nd. Deutsche Bank Aktiengesellschaft assumed coverage on West Pharmaceutical Services in a report on Tuesday, December 13th. They set a “hold” rating and a $250.00 price objective for the company. UBS Group assumed coverage on West Pharmaceutical Services in a research report on Wednesday, November 30th. They set a “neutral” rating and a $250.00 price target for the company. Finally, StockNews.com assumed coverage on West Pharmaceutical Services in a research report on Wednesday, October 12th. They set a “hold” rating for the company. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $266.25.

About West Pharmaceutical Services

(Get Rating)

West Pharmaceutical Services, Inc manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers.

Recommended Stories

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.